Are antihistamines (antihistaminics) safe for use in children under 1 year?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antihistamines Are Not Safe for Children Under 1 Year of Age

Antihistamines should not be used in children under 1 year of age due to significant safety concerns including reported fatalities and lack of established efficacy. 1, 2 First-generation antihistamines in particular pose serious risks to infants, with 41 reported fatalities in children under 2 years associated with diphenhydramine, brompheniramine, and chlorpheniramine between 1969 and 2006. 1

Safety Concerns with Antihistamines in Infants

First-Generation Antihistamines

  • FDA-approved diphenhydramine labeling explicitly states "Do not use" for children under 6 years of age 2
  • Significant mortality risk documented with first-generation antihistamines:
    • 69 fatalities reported in children under 6 years (41 under age 2) associated with diphenhydramine, brompheniramine, and chlorpheniramine 1
    • Common causes of adverse events include overdose, medication errors, and accidental exposures 1
  • Side effects particularly concerning in infants:
    • CNS depression and sedation
    • Paradoxical excitation
    • Anticholinergic effects (urinary retention, mucosal dryness)
    • Cardiovascular effects

Second-Generation Antihistamines

  • While second-generation antihistamines have better safety profiles than first-generation agents, most are not approved for children under 2 years 3, 4
  • Limited safety data exists for infants under 1 year 3
  • Even second-generation antihistamines can cause serious adverse reactions in children, including:
    • Seizures (levocetirizine) 5
    • Severe skin reactions 5

Regulatory and Expert Guidance

  • In 2007, major pharmaceutical companies voluntarily removed cough and cold medications (including antihistamines) for children under 2 years from the OTC market 1
  • FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended against using OTC cough and cold medications in children under 6 years 1
  • Many antihistamines are prescribed off-label in children under 2 years, where safety data is most lacking 3

Age-Specific Recommendations for Antihistamines

Under 1 year:

  • Antihistamines should not be used 1, 2
  • No antihistamines are FDA-approved for this age group
  • High risk of adverse effects including potential fatality

Ages 1-2 years:

  • Limited options with established safety data
  • Some second-generation antihistamines (cetirizine, loratadine) may be used under medical supervision 6, 4
  • First-generation antihistamines should be avoided

Ages 2-6 years:

  • Second-generation antihistamines preferred when necessary 1, 7
  • Cetirizine: 2.5 mg once or twice daily 1
  • Loratadine: 5 mg daily 1

Alternative Approaches for Infants with Allergic Symptoms

For infants under 1 year with allergic symptoms:

  • Identify and avoid triggers
  • Saline nasal irrigation for nasal congestion
  • Maintain adequate hydration
  • Humidification of air
  • Consult with pediatric allergist for severe cases

Key Pitfalls to Avoid

  1. Do not use OTC antihistamine products in infants - these are explicitly contraindicated for children under 6 years 2
  2. Do not assume second-generation antihistamines are completely safe - while they have better safety profiles, they still carry risks in very young children 5
  3. Do not use antihistamines as sedatives for infants - this practice is dangerous and explicitly warned against 2
  4. Do not combine multiple products containing antihistamines - this increases risk of overdose 1

In conclusion, the risks of using antihistamines in children under 1 year of age outweigh any potential benefits. The documented fatalities and serious adverse events, along with explicit FDA labeling against such use, strongly support avoiding these medications in infants.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antihistamines: ABC for the pediatricians.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020

Research

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001

Guideline

Allergic Rhinitis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.